Biobank
/
Eastern Norway

Bionor Pharma Asa

Africa
Asia
Denmark
Europe
North America
Oceania
South America
South Asia
Sweden
West Asia
  • Finance
    Total revenue: 1.851
    Operating profit: -12.95
    Operating profit before tax: -55.608
    Total assets: 1.430.020
    Total equity: 1.424.547
    Currency: NOK (all numbers in thousands)
  • Management
    Board Chairman:
    Simen Thorsen


    Board Members:
    Bente M Søfteland Bøhler
    Heidi Sørensen Austbø
    Runar Vatne
    Sofia Katarina Finneng
    Tore Aksel Voldberg
    Øystein Arnulf Landvik



    General Manager:
    Andreas Martinussen


    Subsidiary companies:
    Largest shareholders:
    N/A
    Biobank, Biotechnology, Health Care, Pharmacological Treatments (New Medicines & Therapies), Terapeutica, Therapeutic agents,